RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+19.56%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$940M
AUM Growth
+$940M
(-11%)
Cap. Flow
-$249M
Cap. Flow
% of AUM
-26.46%
Top 10 Holdings %
Top 10 Hldgs %
62.65%
Holding
57
New
1
Increased
–
Reduced
32
Closed
9
Top Buys
| 1 |
HNGE
Hinge Health, Inc.
HNGE
|
$15.5M |
Top Sells
| 1 |
Amicus Therapeutics
FOLD
|
$47.8M |
| 2 |
Scholar Rock
SRRK
|
$16.6M |
| 3 |
Cogent Biosciences
COGT
|
$12.7M |
| 4 |
Boston Scientific
BSX
|
$11.6M |
| 5 |
Krystal Biotech
KRYS
|
$10.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
26
DELISTED
Verve Therapeutics
VERV
| $8.31M | 0.88% |
740,261
-466,903
| -39% | -$5.24M |
|
|
CBLL
27
CeriBell, Inc. Common Stock
CBLL
$426M
| $8.15M | 0.87% |
435,239
| – | – |
|
28
Keros Therapeutics
KROS
$640M
| $7.38M | 0.79% |
552,506
| – | – |
|
29
Celldex Therapeutics
CLDX
$1.57B
| $6.98M | 0.74% |
343,026
-247,149
| -42% | -$5.03M |
|
|
30
Amicus Therapeutics
FOLD
$2.42B
| $6.81M | 0.73% |
1,188,998
-8,344,671
| -88% | -$47.8M |
|
31
Nuvation Bio
NUVB
$1.08B
| $5.91M | 0.63% |
3,031,009
| – | – |
|
32
Establishment Labs
ESTA
$1.11B
| $5.83M | 0.62% |
136,495
-198,871
| -59% | -$8.49M |
|
33
Prime Medicine
PRME
$595M
| $5.12M | 0.55% |
2,074,350
| – | – |
|
34
RAPT Therapeutics
RAPT
$187M
| $5.05M | 0.54% |
630,686
-5,844,631
| -90% | -$1.43M |
|
35
Penumbra
PEN
$10.5B
| $4.83M | 0.51% |
18,818
-4,025
| -18% | -$1.03M |
|
36
Shattuck Labs
STTK
$61.3M
| $4.39M | 0.47% |
5,539,724
| – | – |
|
37
Atara Biotherapeutics
ATRA
$88.7M
| $3.41M | 0.36% |
441,701
| – | – |
|
|
IGMS
38
DELISTED
IGM Biosciences
IGMS
| $3.31M | 0.35% |
2,952,131
| – | – |
|
39
LAVA Therapeutics
LVTX
$41.3M
| $2.74M | 0.29% |
2,074,372
| – | – |
|
40
Ventyx Biosciences
VTYX
$184M
| $2.39M | 0.25% |
1,114,529
-455,264
| -29% | -$974K |
|
41
Repare Therapeutics
RPTX
$73.9M
| $2.2M | 0.23% |
1,586,174
-298,215
| -16% | -$415K |
|
42
Xeris Biopharma Holdings
XERS
$1.27B
| $2.11M | 0.22% |
451,099
| – | – |
|
43
Pliant Therapeutics
PLRX
$105M
| $1.89M | 0.2% |
1,632,577
-420,982
| -21% | -$488K |
|
44
Invivyd
IVVD
$218M
| $1.63M | 0.17% |
2,285,320
| – | – |
|
45
ALX Oncology
ALXO
$54.6M
| $1.41M | 0.15% |
3,391,455
-249,379
| -7% | -$104K |
|
|
BOLD
46
Boundless Bio
BOLD
$25.7M
| $595K | 0.06% |
589,034
-136,170
| -19% | -$138K |
|
47
4D Molecular Therapeutics
FDMT
$302M
| $416K | 0.04% |
112,168
-885,067
| -89% | -$3.28M |
|
|
KLRS
48
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $221K | 0.02% |
82,955
| – | – |
|
|
ORKA
49
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
| – | – |
-386,963
| Closed | -$3.97M |
|
50
Insulet
PODD
$24.2B
| – | – |
-27,109
| Closed | -$7.12M |
|